Zydus Lifesciences to manufacture and supply Sagents Caffeine Citrate Oral Solution

21 Apr 2022 , 01:34 AM

Zydus Lifesciences announced that it will be manufacturing and supplying Sagents Caffeine Citrate Oral Solution in the strength of 60 mg per 3 mL 20 mg per mL Single-dose Vial US RLD CAFCIT from its injectables facility at Jarod Gujarat India The company announced that it received the Prior Approval Supplement PAS Approval from the US Food and Drug Administration USFDA which allows for a site transfer and manufacturing of the drug at Jarod This product is indicated for the short-term treatment of a breathing problem Apnea in premature infants Caffeine blocks certain proteins adenosine receptors which leads to improved breathing in these infants